[Antibioprophylaxis of Meningococcus group B meningitis. Must we implicate the use of the spiramycin].
A fatal meningitis due to a spiramycin-sensitive group B Neisseria meningitidis occurred 13 days after interruption of a prophylactic antimicrobial therapy with spiramycin. The efficacy of recommended antimicrobial preventive treatment is discussed with regard to this case, other published cases and to the known partial and short term eradication of the naso-pharyngeal carriage of Neisseria meningitidis.
Garre
M
M
L'Emeillat
M
M
Garo
B
B
Boles
J M
JM
D000328:Adult; D005260:Female; D006801:Humans; D007933:Leucomycins / Q000627:therapeutic use*; D008585:Meningitis, Meningococcal / Q000517:prevention & control*; D008911:Minocycline / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
D007933:Leucomycins; D008911:Minocycline; D012293:Rifampin
Antibioprophylaxie de la méningite à Méningocoque sérogroupe B. Faut-il remettre en cause l'emploi de la spiramycine?